Clinical utility of MR/ultrasound fusion-guided biopsy in patients with lower suspicion lesions on active surveillance for low-risk prostate cancer

Urologic Oncology: Seminars and Original Investigations(2022)

引用 0|浏览11
暂无评分
摘要
•Men with low-risk CaP on AS with PI-RADS 2 and 3 have 18% risk of upgrade to csCaP.•PSAD could stratify patients at highest risk for upgrade despite favorable imaging.•In men with PIRADS 2 lesions with PSAD ≤0.12 biopsy can be avoided.•In men with PIRADS 3 lesions with PSAD >0.1, there is a >10% miss rate of csCaP.
更多
查看译文
关键词
Active surveillance,Prostate cancer,PIRADS,Lower suspicion lesions
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要